Innovent Biologics (1801 HK) Mazdutide (IBI362) to become the best GLP-1 drug for obesity in China
Far-reaching impact of prime rate hike on China real estate investment market
China Economy – Mild Reflation after Reopening
China Property Sector NBS Dec data in line, still in bottoming process
China Property Sector: NBS Aug data in-line, expect better recovery in SepOct but sustainability is uncertain
China’s Economy Weekly：Production Growth Momentum Slightly Weakens, Financial Market Caught in Liquidity Trap
电子行业周报：IC CHINA 归来再看中国半导体发展
DTZ China Insight
China Software & IT Services: Year of rabbit: still about localization
standing-out-in-chinas-private-equity-market-an-interview-with-frank-su-vf
公众号
小程序
社群
公众号小程序社群